Valeant On Track With Debt-Reduction Goals, But Will It Be Enough?
Executive Summary
The troubled firm has pushed back its greatest debt burden until 2020, but new products are unlikely to fill sales gap. Valeant says its GI unit is showing positive signs and that a restructuring of the derm commercial unit is nearing completion.